5,0
20 mai 2026
Employé (actuel), plus d'un an
Uppal
Recommande
Approbation du PDG
Perspective commerciale
Avantages
The company in terms of its services/products and global reach is amazing. Excelra possesses premium datasets for Drug Discovery which include GOSTAR and GOBIOM.
Inconvénients
There are no cons as I have seen in this company